开云app官网登录入口网页版-官方正版

#抗肿瘤坏死因子α#

8篇内容 | 892人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2224678, encodeId=d5a822246e875, content=<a href='/topic/show?id=2e6e6e0315d' target=_blank style='color:#2F92EE;'>#炎症性肠病#</a> <a href='/topic/show?id=848de9023d1' target=_blank style='color:#2F92EE;'>#维多珠单抗#</a> <a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=AJG：维多珠单抗与抗肿瘤坏死因子药物治疗炎症性肠病的严重感染风险比较, objectType=article, longId=842317, objectId=02e384231ecf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240807/1723028407186_8538692.png, objectUrl=/article/show_article.do?id=02e384231ecf, replyNumber=0, likeNumber=14, createdTime=2024-09-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=02e384231ecf, moduleTitle=AJG：维多珠单抗与抗肿瘤坏死因子药物治疗炎症性肠病的严重感染风险比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=02e384231ecf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1967429, encodeId=8b01196e42941, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率, objectType=article, longId=198649, objectId=e55f19864904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55f19864904, replyNumber=0, likeNumber=56, createdTime=2021-03-18, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55f19864904, moduleTitle=IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e55f19864904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967428, encodeId=6cd5196e4281e, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, objectType=article, longId=186637, objectId=713418663e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713418663e69, replyNumber=0, likeNumber=56, createdTime=2020-02-24, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713418663e69, moduleTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=713418663e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967427, encodeId=bf20196e4273a, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色, objectType=article, longId=164331, objectId=cce81643312a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cce81643312a, replyNumber=0, likeNumber=62, createdTime=2020-01-19, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cce81643312a, moduleTitle=AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cce81643312a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967424, encodeId=9326196e42479, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=JCC：抗肿瘤坏死因子α在治疗炎症性肠病患者并不增加淋巴瘤发生的风险, objectType=article, longId=150311, objectId=3c4215031151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c4215031151, replyNumber=0, likeNumber=68, createdTime=2019-04-03, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c4215031151, moduleTitle=JCC：抗肿瘤坏死因子α在治疗炎症性肠病患者并不增加淋巴瘤发生的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3c4215031151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967426, encodeId=6ed9196e426fc, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=J Endod：罹患炎症性肠炎患者接受抗肿瘤坏死因子α治疗对根尖周炎愈合的影响, objectType=article, longId=153379, objectId=d92f1533e95c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d92f1533e95c, replyNumber=0, likeNumber=61, createdTime=2018-12-21, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d92f1533e95c, moduleTitle=J Endod：罹患炎症性肠炎患者接受抗肿瘤坏死因子α治疗对根尖周炎愈合的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d92f1533e95c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967425, encodeId=b5d6196e425f0, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议, objectType=article, longId=150929, objectId=479815092966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=479815092966, replyNumber=0, likeNumber=45, createdTime=2018-12-03, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=479815092966, moduleTitle=2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=479815092966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967423, encodeId=3d1e196e423b0, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=GUT：炎症性肠病患者接受抗肿瘤坏死因子α治疗前疗效预测方法研究, objectType=article, longId=141669, objectId=852a141669f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=852a141669f5, replyNumber=0, likeNumber=64, createdTime=2019-03-15, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=852a141669f5, moduleTitle=GUT：炎症性肠病患者接受抗肿瘤坏死因子α治疗前疗效预测方法研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=852a141669f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1967422, encodeId=8588196e422b6, content=<a href='/topic/show?id=1dae55641d6' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子α#</a>, objectTitle=抗肿瘤坏死因子α单克隆抗体治疗炎症性肠病专家共识(2017), objectType=article, longId=115178, objectId=15401151e8a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15401151e8a9, replyNumber=0, likeNumber=43, createdTime=2018-09-06, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15401151e8a9, moduleTitle=抗肿瘤坏死因子α单克隆抗体治疗炎症性肠病专家共识(2017), moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=15401151e8a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

抗肿瘤坏死因子α

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#炎症性肠病# #维多珠单抗# #抗肿瘤坏死因子α#

AJG：维多珠单抗与抗肿瘤坏死因子药物治疗炎症性肠病的严重感染风险比较

2024-09-08发表于上海

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率

2021-03-18

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究

2020-02-24

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色

2020-01-19

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

JCC：抗肿瘤坏死因子α在治疗炎症性肠病患者并不增加淋巴瘤发生的风险

2019-04-03

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

J Endod：罹患炎症性肠炎患者接受抗肿瘤坏死因子α治疗对根尖周炎愈合的影响

2018-12-21

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

2018 台湾应用全身性抗肿瘤坏死因子α治疗非感染性葡萄膜炎建议

2018-12-03

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

GUT：炎症性肠病患者接受抗肿瘤坏死因子α治疗前疗效预测方法研究

2019-03-15

meichuangyi (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子α#

抗肿瘤坏死因子α单克隆抗体治疗炎症性肠病专家共识(2017)

2018-09-06

科室
- - 订阅+
  - 更多科室
工具
服务